Lord, Abbett & Co. LLC Personalis, Inc. Transaction History

Lord, Abbett & Co. LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$8.73 - $12.95 $2.57 Million - $3.81 Million	-294,123 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$14.16 - $25.34 $224,818 - $402,323	-15,877 Reduced 5.12%	294,123 $4.32 Million
Q2 2019 Aug 14, 2019	BUY	$27.0 - $30.25 $8.37 Million - $9.38 Million	310,000 New	310,000 $8.42 Million

30.3M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $279M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.